CMS Proposes Major Changes to Skin Substitutes Reimbursement: What You Need to Know
SmartTRAK's industry experts discuss CMS’ proposed changes to skin substitutes reimbursement and their potential effects on wound care practices.
On Monday, July 14, the Centers for Medicare & Medicaid Services (CMS) released new proposals for the reimbursement of Skin Substitutes in the physician fee schedule sites of care. SmartTRAK estimates the 2024 US Skin Substitutes Market at almost $8B, with over three-quarters of that amount coming from the Physician Office and Mobile+ sites of care.
In the following video, SmartTRAK Wound General Manager Kris Flinn is joined by Senior Analysts Jay Merkel and Elizabeth Anderson to explain the CMS proposals and explore their potential impacts on US wound care (17:33 min).
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
